Stilla Technologies completes €16 Million ($18 Million) Series A financing to commercialize its novel digital PCR system and develop clinical applications

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2R0aj6q
via IFTTT